Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Mikhail Valentinovich Rozantsev has a portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action, which is being reviewed by 1 distinct examiner. This single action represents the entire active prosecution workload for this portfolio, suggesting a very specific technical focus or a nascent stage of development.
The examination is being conducted within 1 distinct art unit. KAMM, JUDITH MARIE is the busiest examiner for this portfolio, currently managing 1 pending office action. Since the busiest examiner pending count is 1, this examiner is responsible for the only active matter in the portfolio. Their individual expertise in biotechnology will be the primary influence on the success of the application.
For a practitioner, the presence of 1 pending office action under 1 distinct examiner in 1 distinct art unit means that the prosecution strategy must be highly targeted. There are no other pending cases to provide insight into how different examiners might view the technology. Success depends on understanding the specific tendencies of this one examiner and the prior art typically cited within their art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KAMM, JUDITH MARIE | 1 | 42.2% | +57.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18720650 | METHOD FOR ENHANCING THE YIELD OF GRAIN CROPS | KAMM, JUDITH MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18720650 | METHOD FOR ENHANCING THE YIELD OF GRAIN CROPS | KAMM, JUDITH MARIE | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18720650 | METHOD FOR ENHANCING THE YIELD OF GRAIN CROPS | KAMM, JUDITH MARIE | 1611 | §103§112 | Final Rejection | — | Pending | Jun 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMikhail Valentinovich Rozantsev has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Judith Marie Kamm has the most, with 1 of Mikhail Valentinovich Rozantsev's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.